Mission

Redoxis have a dedicated research team with long experience and specialist competence in immunology, animal models and drug target validation. By combining close academic collaborations with a cost-efficient, structural and flexible target validation process, we have specialized in efficient validation of novel drug- targets for continued preclinical validation and candidate drug selection. During the lead development phase of novel drug candidates, Redoxis actively searches for partnership with venture capitalists or the pharma industry for preclinical documentation and clinical development.

Ultimately, it is our vision to Identify and Develop new safe and effective treatments for autoimmune diseases.